244 related articles for article (PubMed ID: 21316835)
21. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
Abed Y; Baz M; Boivin G
J Infect Dis; 2009 Jan; 199(2):180-3. PubMed ID: 19046066
[TBL] [Abstract][Full Text] [Related]
22. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.
Collins PJ; Haire LF; Lin YP; Liu J; Russell RJ; Walker PA; Skehel JJ; Martin SR; Hay AJ; Gamblin SJ
Nature; 2008 Jun; 453(7199):1258-61. PubMed ID: 18480754
[TBL] [Abstract][Full Text] [Related]
23. Selective binding of antiinfluenza drugs and their analogues to 'open' and 'closed' conformations of H5N1 neuraminidase.
Wang P; Zhang JZ
J Phys Chem B; 2010 Oct; 114(40):12958-64. PubMed ID: 20860351
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
Takano R; Kiso M; Igarashi M; Le QM; Sekijima M; Ito K; Takada A; Kawaoka Y
J Infect Dis; 2013 Jan; 207(1):89-97. PubMed ID: 23053629
[TBL] [Abstract][Full Text] [Related]
25. Computational studies of H5N1 influenza virus resistance to oseltamivir.
Wang NX; Zheng JJ
Protein Sci; 2009 Apr; 18(4):707-15. PubMed ID: 19309695
[TBL] [Abstract][Full Text] [Related]
26. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
[TBL] [Abstract][Full Text] [Related]
27. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S
J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
[TBL] [Abstract][Full Text] [Related]
28. Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt.
Earhart KC; Elsayed NM; Saad MD; Gubareva LV; Nayel A; Deyde VM; Abdelsattar A; Abdelghani AS; Boynton BR; Mansour MM; Essmat HM; Klimov A; Shuck-Lee D; Monteville MR; Tjaden JA
J Infect Public Health; 2009; 2(2):74-80. PubMed ID: 20701864
[TBL] [Abstract][Full Text] [Related]
29. Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant.
García-Sosa AT; Sild S; Maran U
J Chem Inf Model; 2008 Oct; 48(10):2074-80. PubMed ID: 18847186
[TBL] [Abstract][Full Text] [Related]
30. The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern.
Schaduangrat N; Phanich J; Rungrotmongkol T; Lerdsamran H; Puthavathana P; Ubol S
J Gen Virol; 2016 Jun; 97(6):1311-1323. PubMed ID: 26935590
[TBL] [Abstract][Full Text] [Related]
31. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
Duwe S; Schweiger B
J Virol Methods; 2008 Nov; 153(2):134-41. PubMed ID: 18725246
[TBL] [Abstract][Full Text] [Related]
32. Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir.
Rameix-Welti MA; Agou F; Buchy P; Mardy S; Aubin JT; Véron M; van der Werf S; Naffakh N
Antimicrob Agents Chemother; 2006 Nov; 50(11):3809-15. PubMed ID: 16940075
[TBL] [Abstract][Full Text] [Related]
33. Virology. Helping the resistance.
Holmes EC
Science; 2010 Jun; 328(5983):1243-4. PubMed ID: 20522766
[No Abstract] [Full Text] [Related]
34. How does each substituent functional group of oseltamivir lose its activity against virulent H5N1 influenza mutants?
Rungrotmongkol T; Udommaneethanakit T; Malaisree M; Nunthaboot N; Intharathep P; Sompornpisut P; Hannongbua S
Biophys Chem; 2009 Nov; 145(1):29-36. PubMed ID: 19733000
[TBL] [Abstract][Full Text] [Related]
35. Neuraminidase mutations conferring resistance to laninamivir lead to faster drug binding and dissociation.
McKimm-Breschkin JL; Barrett S
Antiviral Res; 2015 Feb; 114():62-6. PubMed ID: 25499124
[TBL] [Abstract][Full Text] [Related]
36. A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
An J; Lee DC; Law AH; Yang CL; Poon LL; Lau AS; Jones SJ
J Med Chem; 2009 May; 52(9):2667-72. PubMed ID: 19419201
[TBL] [Abstract][Full Text] [Related]
37. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.
Lackenby A; Democratis J; Siqueira MM; Zambon MC
Antivir Ther; 2008; 13(6):809-20. PubMed ID: 18839782
[TBL] [Abstract][Full Text] [Related]
38. The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir.
Phillips AM; Shoulders MD
J Mol Biol; 2016 Feb; 428(3):533-537. PubMed ID: 26748011
[No Abstract] [Full Text] [Related]
39. Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
Enserink M
Science; 2009 Feb; 323(5918):1162-3. PubMed ID: 19251605
[No Abstract] [Full Text] [Related]
40. Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases.
Le L; Lee EH; Hardy DJ; Truong TN; Schulten K
PLoS Comput Biol; 2010 Sep; 6(9):. PubMed ID: 20885781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
